As more countries around the world reject unmerited patents for Sovaldi®, I-MAK Files Two New U.S. Patent Challenges on Gilead’s Hepatitis C Portfolio Press Release
Partner with us now to build a more just and equitable medicine system for all. Notice: JavaScript is required for this content.